DiaMedica Therapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Note 10 - Shareholders' Equity (Tables)

9 Months Ended

Sep. 30, 2024

	September 30, 2024
Common shares issuable upon exercise of employee and non-employee stock options		4,632,438
Common shares issuable upon settlement of deferred stock units		284,886
Common shares issuable upon vesting and settlement of restricted stock units		5,913
Shares available for grant under the Amended and Restated 2019 Omnibus Incentive Plan		3,005,399
Shares available for grant under the 2021 Employment Inducement Incentive Plan		357,500
Total		8,286,136